Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04669171
Title A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma (SIDNEY)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enterome

marginal zone B-cell lymphoma

follicular lymphoma



EO2463 + Lenalidomide + Rituximab

EO2463 + Rituximab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP

No variant requirements are available.